We take our role in your health very seriously. Come in today to see how we can help.
Staying informed is also a great way to stay healthy. Keep up-to-date with all the latest health news here.
04 May
Social Media Videos, Easy Access Raise Risk of Teen Inhalant Use
Two new studies find widespread social media exposure to inhalants is impacting young teens, especially girls.
01 May
High-Intensity Exercise After Breast Cancer Surgery Speeds Recovery, Study Finds
In a new study, breast cancer survivors who completed a three-month high-intensity resistance training program improved strength, mobility, balance, and muscle mass—supporting a faster return to everyday activities.
30 Apr
Sleep & Anxiety Meds in Pregnancy: What New Research Shows
A new study finds no link between sedative use during pregnancy and neurodevelopmental conditions like ADHD and autism in children.
Newer Migraine Drugs Reduce Headache Days With Fewer Side Effects
Chronic migraine can be difficult to treat — but new research is helping identify the most effective options.
In a large new review, published today in the Annals of Internal Medicine, researchers analyzed 43 clinical trials involving adults with chronic migraine, defined as headaches on 15 or more days a month.
The st...
- HealthDay Staff HealthDay Reporter
- |
- May 5, 2026
- |
- Full Page
New Warning Labels Might Help People Cut Back On Drinking
Alcoholic beverages in the United States carry a warning label, but you’d be forgiven if they leave little impression.
In place since 1988, the label states the risks of drinking during pregnancy or while driving, along with a general notice that alcohol “may cause health problems.”
These small labels often go unnot...
- Dennis Thompson HealthDay Reporter
- |
- May 5, 2026
- |
- Full Page
New Drug Combo Effective Against Treatment-Resistant IBD, Trials Show
A new combination drug therapy could help people with inflammatory bowel disease (IBD) for whom other medicines have stopped working, according to a pair of new studies.
The treatment combines two drugs already approved to treat inflammatory diseases, guselkubam (Tremfya) and golimumab (Simponi), researchers are reporting today at a joint ...
- Dennis Thompson HealthDay Reporter
- |
- May 5, 2026
- |
- Full Page
Ozempic Can Curb Cravings in Alcohol Use Disorder, Landmark Trial Finds
Ozempic can help people who are battling alcoholism, a major new clinical trial has concluded.
People with alcohol use disorder taking semaglutide (Ozempic/Wegovy) had significantly fewer heavy drinking days compared to patients assigned a placebo, researchers reported May 2 in The Lancet.
People on semaglutide also dr...
- Dennis Thompson HealthDay Reporter
- |
- May 5, 2026
- |
- Full Page
US on the Brink of Losing Measles-free Status, Study Warns
The United States is moving quickly toward losing its status as a measles-free nation, a new study says.
The nation has missed four of seven markers set by the U.S. Centers for Disease Control and Prevention (CDC) after experts declared measles eradicated in 2000, researchers report in The Lancet.
These include a surge in me...
- Dennis Thompson HealthDay Reporter
- |
- May 5, 2026
- |
- Full Page
FDA Green Lights Expanded Access to Pancreatic Cancer Drug, Daraxonrasib
The U.S. Food and Drug Administration (FDA) granted expanded access for the use of an experimental pancreatic cancer drug, daraxonrasib.
This means the drug will be available for early access to those who previously received conventional treatment for metastatic pancreatic ductal adenocarcinoma (PDAC). A healthcare provider must requ...
- Andria Park Huynh HealthDay Reporter
- |
- May 4, 2026
- |
- Full Page
Health News is provided as a service to Atlantic Pharmacy site users by HealthDay. Atlantic Pharmacy nor its employees, agents, or contractors, review, control, or take responsibility for the content of these articles. Please seek medical advice directly from your pharmacist or physician.
Copyright © 2026 HealthDay All Rights Reserved.
Our Affiliations
